Physician profile
Devang M Desai
NPI 1013110998
$206,267.77
in general payments reported to CMS, 2019-2025
49 companies · $17K in 2025
The $17K reported for 2025 was more than what 96% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $29K · 2020: $11K · 2021: $25K · 2022: $54K · 2023: $53K · 2024: $17K · 2025: $17K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $37K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $29K · Food and Beverage: $12K · Travel and Lodging: $7,196 · Long Term Medical Supply Or Device Loan: $1,902.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $36,525.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $29,000.00 |
| Food and Beverage | $12,136.23 |
| Travel and Lodging | $7,195.86 |
| Long Term Medical Supply Or Device Loan | $1,902.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $116,101.11 | 2019-2024 | Xarelto |
| Edwards Lifesciences Corporation | $69,319.43 | 2019-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Sapien 3 Ultra Resilia, Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Medtronic, INC. | $7,439.54 | 2021-2025 | Micra, Reveal Linq, Advisa Dr Mri Surescan |
| Boston Scientific Corporation | $2,565.65 | 2020-2025 | Watchman Flx, Watchman Access System, Farapulse |
| Abbott Laboratories | $2,139.52 | 2019-2025 | Mitraclip, Gallant, Aveir |
| Angiodynamics, INC. | $1,902.22 | 2024-2025 | Venacure 1470 Pro |
| Novartis Pharmaceuticals Corporation | $1,245.42 | 2019-2025 | |
| Abiomed | $515.02 | 2019-2025 | Impella |
| Actelion Pharmaceuticals US, INC. | $467.03 | 2019-2025 | Opsumit, Uptravi, Opsynvi |
| Amgen INC. | $388.86 | 2019-2024 | Repatha |
| Medtronic Vascular, INC. | $357.81 | 2019-2020 | |
| E.R. Squibb & Sons, L.L.C. | $350.98 | 2019-2025 | Camzyos, Eliquis |
| Boehringer Ingelheim Pharmaceuticals, INC. | $332.27 | 2019-2023 | Jardiance |
| Pfizer INC. | $318.68 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $293.66 | 2021-2025 | Verquvo, Belsomra, Winrevair |
Show all 49 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $203.08 | 2021-2023 | |
| Scpharmaceuticals INC. | $189.13 | 2023-2025 | |
| Alnylam Pharmaceuticals INC. | $173.41 | 2023-2025 | Amvuttra, Onpattro |
| Biotronik INC. | $171.42 | 2019-2025 | Biomonitor, Amvia Edge |
| Astrazeneca Pharmaceuticals LP | $165.78 | 2019-2024 | Wainua, Farxiga |
| Atricure, INC. | $163.37 | 2024-2025 | Atriclip Laa Exclusion System |
| Philips North America LLC | $135.70 | 2022-2024 | (Cm9) Amb Mon & Diag Und |
| United Therapeutics Corporation | $129.66 | 2021-2025 | Tyvaso, Tyvaso, Orenitram |
| Ge Healthcare | $123.81 | 2019 | |
| Esperion Therapeutics, INC. | $121.20 | 2021-2024 | Nexletol |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $113.50 | 2023 | Lifevest |
| Regeneron Healthcare Solutions, INC. | $109.01 | 2019 | |
| Cardiva Medical, INC. | $70.36 | 2022-2024 | Cardiva Vascade Mvp Vvcs 6-12f |
| Shockwave Medical, INC | $66.89 | 2022-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Penumbra, INC. | $63.94 | 2025 | Indigo System |
| Cvrx, INC. | $50.35 | 2025 | Barostim Neo System |
| Kiniksa Pharmaceuticals International, Plc | $48.59 | 2024 | Arcalyst |
| Irhythm Technologies, INC. | $45.81 | 2023-2024 | Zio Xt Patch, Zio Monitor |
| Akcea Therapeutics, INC. | $44.03 | 2019 | |
| Bridgebio Pharma, INC. | $36.00 | 2025 | Attruby |
| Biosense Webster, INC. | $32.02 | 2024 | Carto 3 |
| Amarin Pharma, INC. | $31.69 | 2019 | |
| Heartflow, INC. | $31.42 | 2024 | |
| Livanova USA, INC. | $28.06 | 2020 | |
| W. L. Gore & Associates, INC. | $24.91 | 2023 | Gore Cardioform Septal Occluder |
| Cardinal Health 200 LLC | $21.15 | 2019 | |
| Baxter Healthcare | $20.96 | 2023 | Hillrom - Cardiac Ambulatory Monitor |
| Lexicon Pharmaceuticals, INC. | $20.47 | 2023 | Inpefa |
| Kowa Pharmaceuticals America, INC. | $18.46 | 2021 | |
| Tactile Systems Technology INC | $18.02 | 2022 | |
| Alexion Pharmaceuticals, INC. | $16.83 | 2021 | |
| Lilly USA, LLC | $15.92 | 2025 | Mounjaro, Zepbound |
| Novo Nordisk INC | $14.52 | 2024 | Wegovy |
| Cardiovascular Systems INC. | $11.10 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Devang Desai listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.